Greenwich Lifesciences (GLSI) earnings

· Market cap $229M

In the quarter ended June 2026, Greenwich Lifesciences had revenue of —, and diluted EPS of -0.27.

On August 11, 2026 it reported EPS of -0.27 against an estimate of -0.33 (beat).

The next report is expected on Friday, November 13, 2026, with EPS expected around -0.34.

Report dates

ReportDateTimeEPS estimateEPS reported
NextFri Nov 13, 2026 — -0.34 —
LastTue Aug 11, 2026 — -0.33 -0.27

Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.

Quarterly results

The last 12 quarters from Greenwich Lifesciences's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.

Quarter endedRevenueGrowthEPS (diluted)GrowthOp. marginFiled
Jun 30, 2026— — -0.27 — — 2026-08-11
Mar 31, 2026— — -0.39 — — 2026-06-04
Dec 31, 2025— — — — — 2026-06-01
Sep 30, 2025— — -0.27 — — 2025-11-14
Jun 30, 2025— — -0.28 — — 2025-08-14
Mar 31, 2025— — -0.21 — — 2025-05-20
Dec 31, 2024— — — — — 2025-04-15
Sep 30, 2024— — -0.20 — — 2024-11-14
Jun 30, 2024— — -0.20 — — 2024-08-14
Mar 31, 2024— — -0.19 — — 2024-05-20
Dec 31, 2023— — — — — 2024-04-15
Sep 30, 2023— — -0.19 — — 2023-10-19
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for GLSI.
Open GLSI in Investingly

Questions

When does Greenwich Lifesciences report earnings?

Greenwich Lifesciences's next earnings report is expected on November 13, 2026.

How did Greenwich Lifesciences do last quarter?

In the quarter ended June 2026, Greenwich Lifesciences had revenue of —, and diluted EPS of -0.27.

From Greenwich Lifesciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.